IGM Biosciences, Inc. (IGMS)

IGM Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	378	485	728	952	2,711	1,165
Market Cap Growth	-4.39%	-33.39%	-23.49%	-64.87%	132.62%	-
Enterprise Value	125	187	342	751	2,357	955
PE Ratio	-	-1.97	-3.29	-5.76	-33.32	-27.01
PS Ratio	179.45	227.82	681.46	-	-	-
PB Ratio	2.34	2.39	2.54	3.89	7.10	4.85
P/FCF Ratio	-2.92	-2.37	-45.36	-6.89	-31.75	-24.56
P/OCF Ratio	-3.09	-2.52	-124.46	-7.62	-39.93	-25.83
EV/Sales Ratio	59.19	88.02	319.74	-	-	-
EV/EBITDA Ratio	-1.41	-0.81	-1.62	-4.77	-30.30	-23.42
EV/EBIT Ratio	-1.33	-0.76	-1.55	-4.54	-28.97	-22.15
EV/FCF Ratio	-1.61	-0.92	-21.28	-5.43	-27.60	-20.13
Debt / Equity Ratio	0.25	0.20	0.14	0.12	0.03	0.06
Debt / EBITDA Ratio	-0.18	-0.17	-0.20	-0.18	-0.16	-0.36
Debt / FCF Ratio	-0.21	-0.20	-2.56	-0.21	-0.14	-0.31
Quick Ratio	7.75	7.96	9.57	8.29	21.25	25.31
Current Ratio	7.98	8.18	9.81	8.67	21.65	26.04
Asset Turnover	0.01	0.01	0.00	0	0	0
Return on Equity (ROE)	-108.10%	-103.20%	-74.00%	-54.70%	-32.50%	-49.50%
Return on Assets (ROA)	-54.00%	-53.50%	-46.70%	-48.50%	-29.80%	-32.50%
Return on Capital (ROIC)	-125.60%	-108.09%	-69.41%	-60.41%	-21.13%	-17.45%
Earnings Yield	-62.72%	-50.78%	-30.35%	-17.35%	-3.00%	-3.70%
FCF Yield	-51.51%	-42.17%	-2.20%	-14.52%	-3.15%	-4.07%
Buyback Yield / Dilution	-35.19%	-25.92%	-24.09%	-8.88%	-241.82%	-1953.40%
Total Shareholder Return	-35.19%	-25.92%	-24.09%	-8.88%	-241.82%	-1953.40%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).